Technology bolsters the pharma industry; creates M&A opportunities

Technology bolsters the pharma industry; creates M&A opportunities

Technology is playing an increasingly important role in the life sciences and pharmaceutical industry, leading to an increase in M&AClick to watch
The changing face of B2B sales

The changing face of B2B sales

The B2B sales function of today must adapt to the evolving expectations of its customers. In a recent webinar, CIL’s Jon Whiteman and Axel Leichum were joined by Allister Frost, former head of digital marketing strategy at Microsoft, to discuss the changing face of B2B sales.Click to watch
VCDD: Improving process, predictability and price

VCDD: Improving process, predictability and price

A recent CIL survey of investment banks found that the use of vendor commercial due diligence has increased significantly in the last ten years as vendors and buyers alike recognise its value in transaction processes. In this presentation, we outline the key benefits VCDD brings to the sales process.Click to watch
Sign up to our mailing list to receive our latest insights.